Literature DB >> 3560143

Pulmonary eosinophilia associated with naproxen therapy.

K C Flint, N M Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3560143      PMCID： PMC1290689          DOI： 10.1177/014107688708000221

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  4 in total

1.  Lung changes associated with phenylbutazone treatment.

Authors:  J G Thurston; P Marks; D Trapnell
Journal:  Br Med J       Date:  1976-12-11

Review 2.  The spectrum of drug-induced pulmonary disease.

Authors:  E C Rosenow
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

3.  Serial changes in left ventricular ejection fraction in the early hours after aortocoronary bypass grafting.

Authors:  H R Phillips; J E Carter; R D Okada; F H Levine; C A Boucher; M Osbakken; D Lappas; M J Buckley; G M Pohost
Journal:  Chest       Date:  1983-01       Impact factor: 9.410

4.  Pulmonary infiltrates associated with naproxen.

Authors:  A J Buscaglia; F E Cowden; H Brill
Journal:  JAMA       Date:  1984-01-06       Impact factor: 56.272
  4 in total
  2 in total

1.  Rash and pulmonary eosinophilia associated with fenbufen.

Authors:  G H Burton
Journal:  BMJ       Date:  1990-01-13

Review 2.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.